Trading or manufacturing medium- and high-risk medical devices in China requires a license issued by the National Medical Products Administration (NMPA). Whether you are a domestic manufacturer or a foreign company looking to enter the Chinese market, understanding the classification system, registration pathway, and regulatory requirements is essential. This guide covers every aspect of the medical device licensing process in China as of 2026.
The Three Classes of Medical Devices
China classifies medical devices into three categories based on risk level. The classification determines which authority handles registration and the complexity of the approval process.
The higher the class, the more rigorous the pre-market evaluation. Class I devices only require a record filing, while Class II and Class III devices must undergo formal registration and review.
Pre-Market Approval: The NMPA Registration Requirement
All medical devices sold or used in China must complete pre-market product registration with NMPA. The process differs significantly depending on whether the product is manufactured domestically or imported from abroad. There are three levels of regulatory management: the national-level NMPA, provincial-level medical products bureaus, and municipal-level bureaus.
Registration for Imported Medical Devices
Foreign manufacturers must register their devices through the national NMPA. In all cases, a local authorized representative in China must serve as the Marketing Authorization Holder (MAH).
Registration for Domestic Medical Devices
Domestic manufacturers register through different government levels depending on device classification.
Step-by-Step: Imported Medical Device Registration Process
The registration process for imported medical devices is detailed and can take two or more years from start to finish. Below is the complete workflow.
Step 1: Determine Device Classification and Plan Strategy
Begin by confirming which class your device falls under according to the NMPA classification catalogue. This determines the regulatory pathway, documentation requirements, and estimated timeline. Plan your strategy around clinical trial requirements, standards compliance, and the appointment of a local authorized representative.
Step 2: Ensure Compliance with Applicable Standards
Products must meet all relevant national standards (GB), industrial standards (YY), and applicable international standards (ISO/IEC). These cover performance specifications, safety requirements, and inspection methodologies. Verify compliance early, as gaps discovered later will cause significant delays.
Step 3: Type Inspection (Prototype Testing)
Once a production-ready prototype is available, submit it for type inspection at an NMPA-recognized testing institution. This inspection verifies that the device meets all declared standards and specifications. The type inspection process typically takes a minimum of six months, though timelines vary based on device complexity and testing institution workload.
Step 4: Clinical Trials
After receiving the type inspection report, most devices require clinical trials conducted at NMPA-approved clinical trial institutions in China. Clinical trials typically take one year or longer, depending on the device and indication.
Step 5: Prepare Regulatory Documentation
Regulatory document preparation should run concurrently with type inspection and clinical trials. The documentation package includes risk management reports, product technical requirements, quality management system documentation, clinical evaluation reports, and all supporting evidence for safety and efficacy claims.
Step 6: Submit Registration Application and Review
The final step is submission to the Center for Medical Device Evaluation (CMDE). The review proceeds as follows:
Corrective notice: If deficiencies are identified, the applicant receives a corrective notice. All corrections must be submitted within one year of the notice date; failure to respond within this window results in automatic rejection.
Second review: For Class II and Class III devices, a second round of technical review is conducted after corrections are submitted.
Administrative approval: Once technical review is complete, the administrative approval decision is issued within approximately 20 working days.
Fast-Track Approval Pathways
NMPA offers two accelerated review channels for qualifying devices. These pathways can significantly reduce the time to market.
Innovative Medical Device Review
This pathway is designed for genuinely novel devices. To qualify, the device must meet all of the following criteria:
- The applicant holds a core technology patent for the device
- The device is the first of its kind in China
- The device demonstrates significant clinical value over existing alternatives
Medical Device Priority Approval
This pathway covers devices that address unmet clinical needs. Eligible categories include:
- Devices urgently needed in clinical practice
- Devices developed under state key research and development projects
- Devices targeting rare diseases that offer obvious advantages over current options
- Pediatric-specific devices
- Devices for elderly disease management where no current alternatives exist
Documentation Requirements for Registration
The registration dossier for medical devices in China is comprehensive. Below is an overview of the key documents required.
Timeline Summary
The total timeline for imported medical device registration varies widely based on device class, clinical trial requirements, and review cycles. The following estimates represent typical durations.
For devices exempt from clinical trials, the total process may take 18 to 24 months. For devices requiring clinical trials, expect 2 to 4 years from initial planning to approval.
